Lot Release Certificate View

Lot Release Number 2022-03-30-0072
FDA Registered Product/Generic Name RECOMBINANT HEPATITIS B VACCINE
Brand Name AMVAX-B
Dosage Strength 20 mcg/0.5 mL
Dosage Form SUSPENSION FOR INJECTION (I.M.)
Registration Number BR-675
Batch/Lot Number 424
Packaging Lot Packaging Lot (Box & Ampoule): 242
Product Expiration Date 4 April 2024
Issuance Date 1 April 2022